Something about this delivery reminds of the business-card scene from Psycho [0].
> Look at that subtle off-white coloring, the tasteful thickness of it--Oh my God, it even has a watermark..."
We all should hope that it has high specificity for the mutant PCNA, and doesn't affect healthy cells... clinical trials will investigate this.
[0] https://en.m.wikipedia.org/wiki/Proliferating_cell_nuclear_a...
Instead, this would target both healthy and cancerous cells. However, the idea is that the cancer cells are more susceptible to the drug. Healthy cells will be affected, but cancer cells will be affected more, and are more unstable, so losing PCNA will have more of an effect on the cancer cells.
The main idea is to do as much damage to the cancer cells while doing as little to normal cells as possible.
Edit: after reading the paper, the drug is targeting a cancer specific isoform of PCNA. This isn’t a mutation, but a slightly different form of the existing protein. Cancers tend to rely on this specific version, while healthy cells can use a different isoform (or both?). A selective inhibitor for this isoform would be cancer cell specific. There would still be some effect on healthy cells, but not as much as with a traditional cytotoxic chemotherapy.
Edit: exactly -> "It was created to target a specific variant of PCNA found only in cancer cells. This protein is crucial in the body for DNA repair, but targeting it was difficult because of its role in healthy cells. By going after only the variant, it may be possible to selectively target only cancer cells"
From Wikipedia
I wonder how something like that comes about? Is there something special about that isoform that is necessary for tumor growth or what?
It is targeting a mutated version.
https://www.cell.com/cell-chemical-biology/fulltext/S2451-94...
The coding sequence for an isoform is part of the normal gene DNA sequence, but the cells can “choose” which version to make. In this case the caPCNA isoform is the form predominantly expressed in cancer cells.
(There is a mechanism where novel splicing isoforms can be produced by a mutation, but this doesn’t seem to be one of those.)
The drug developers noticed that (a class of) cancer cells involve a shape change in the molecule that clamps on to DNA strands for the purposes of replication and repair. The molecule targets that shape change and thus prevents (a class of) cancer cells from being able to maintain and replicate their DNA.
Cancel cells die and can't replicate = no cancer.
I much prefer your description of the molecule than the one found on its Wikipedia page.
I first thought it was a joke because of the two "HN" bonds hah, pardon me.
"AOH1996 is a very unremarkable-looking molecule - to be honest, it looks like the sort of stuff that you used to see in old combinatorial chemistry libraries in the late 90s and early 2000s, a couple of aryl-rich groups strung together with amide bonds."
https://www.science.org/content/blog-post/new-mode-cancer-tr...
“I hope that human cancers will prove vulnerable to this new mode of attack in the clinic, and that they are not able to mutate around it with new forms of caPCNA too quickly, either.”
Even if this does prove effective in humans, eventually cancer cell defenses will evolve to get around it.
Cancer becomes tolerant to drugs separately for each patient. I.e. initially it isn't resistant, but the drug used on a patient puts evolutionary pressure on the cancer to work around the drug. What this means is that people have more months or years to live, which is great. (I am not a doctor).
The ABVD regime starts with the same baseline on all hodgkin's lymphoma patients, and 'cures' cancer permanently in quite a large number of them.
I know nothing about the FDA but for things like terminal cancer treatment, shouldn't there be a blanket exemption for "if the patient so wish, they can take whatever drugs they want even if unapproved"? When facing certain death, what's the worst that can happen? You die a bit sooner?
Having cancer already sucks enough, having businesses and whatnot vulturing over your condition to sell you shit that doesn't work wouldn't really make it better?
The second way is that drugs/devices are considered against their intended use. So the argument for using more dangerous things is much easier if you are treating brain tumors than common colds. There even are fast-track (e.g. mRNA vaccine for covid) but won't be pulled out for niche uses.
What this doesn't cover is things produced in uncontrolled ways, or "i read this on the internet and want a prescription". I can see how this is frustrating for people who are willing to try anything, but I can also see the liability side.
> "When facing certain death, what's the worst that can happen? You die a bit sooner?"
Part of the problem is you certainly can make things worse, and you can make them systemically more expensive. It's one thing to say "I'm dying anyway and I want to try this" but quite another to add "and if it goes badly I expect you to try and deal with it". No easy answers, really.
https://chat.openai.com/share/28d9b203-1cb5-405b-a109-0f5042...
Basically I wanted to see if your comment, along with the detailed description of the molecular structure, could lead the AI to guess how the compound could be useful. I then proceeded to drop more and more hints and asked it to use those hints along with the structure to guess at a potential mechanism of action. In any case, it certainly helped explain to me what you were talking about!
But, if we know which cells to target and what their structure is, can’t we just extract some healthy cells, reproduce them, kill all cells which would dock to that pill, insert reproduced healthy cells?
So with that we don’t have to care if it attacks healthy cells, or is that reproduction idea not possible?
Look at that molecular structure. Incredible.
Two amide bonds, a completely unremarkable aryl ether and an unsubstituted naphthalene ring system. No fussy weird metals or bonds that need pampering, no chiral carbon atom in sight.
You could probably pay someone a very modest amount of money to end up with kilograms of this stuff, and it would probably not degrade at all under ambient conditions.
I wouldn't be surprised if we soon see desperate, sick, rich people try this out on themselves, skipping FDA approval.
Beautiful, uplifting news. Let's hope the clinical trials proceed without issue.